Reata Pharmaceuticals Inc... (RETA)
NASDAQ: RETA
· Real-Time Price · USD
172.36
0.04 (0.02%)
At close: Sep 25, 2023, 10:00 PM
Reata Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 22.75M | 195K | 914K | 540K | 762K | 914K | 934K | 7.39M | 2.22M | 944K |
Cost of Revenue | 846K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 21.9M | 195K | 914K | 540K | 762K | 914K | 934K | 7.39M | 2.22M | 944K |
Operating Income | 193M | -110.45M | -71.47M | -70.55M | -63.98M | -64.07M | -71.57M | -58.09M | -60.16M | -54.91M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 193M | -116.12M | -85.56M | -79M | -73.56M | -73.81M | -85.17M | -71.85M | -73.35M | -67.47M |
Net Income | 193M | -110.76M | -85.5M | -76.79M | -73.56M | -73.84M | -85.39M | -71.85M | -72.7M | -67.45M |
Selling & General & Admin | 45.69M | 54.88M | 32.02M | 27.27M | 25.14M | 24.84M | 30.56M | 25.74M | 22M | 20.7M |
Research & Development | 57.12M | 55.48M | 47.22M | 43.48M | 39.33M | 39.8M | 41.62M | 39.43M | 40.07M | 34.88M |
Other Expenses | -104K | 288K | 277K | 272K | 273K | -33K | n/a | 4K | -34K | 3K |
Operating Expenses | 103.1M | 110.65M | 79.52M | 71.03M | 64.75M | 64.95M | 72.5M | 65.49M | 62.35M | 55.86M |
Interest Expense | 7.97M | 11.02M | 10.96M | 10.66M | 10.28M | 9.87M | 13.62M | 13.79M | 13.2M | 12.64M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 103.95M | 110.65M | 79.52M | 71.03M | 64.75M | 64.95M | 72.5M | 65.49M | 62.35M | 55.86M |
Income Tax Expense | 7.87M | -5.36M | -55K | -2.21M | -1K | 31K | 218K | n/a | -653K | -15K |
Shares Outstanding (Basic) | 41.51M | 36.95M | 36.32M | 36.54M | 36.47M | 36.41M | 36.39M | 36.39M | 36.3M | 36.2M |
Shares Outstanding (Diluted) | 41.51M | 36.95M | 36.32M | 36.54M | 36.47M | 36.41M | 36.39M | 36.39M | 36.3M | 36.2M |
EPS (Basic) | 5.12 | -3 | -2.35 | -2.1 | -2.02 | -2.03 | -2.35 | -1.97 | -2 | -1.86 |
EPS (Diluted) | 4.65 | -3 | -2.35 | -2.1 | -2.02 | -2.03 | -2.35 | -1.97 | -2 | -1.86 |
EBITDA | 193M | -110.17M | -117.22M | -68.07M | -63.01M | -63.63M | -71.24M | -57.73M | -46.38M | -54.56M |
EBIT | 193M | -110.76M | -81.74M | -68.34M | -63.28M | -63.94M | -71.55M | -58.05M | -46.66M | -54.83M |
Depreciation & Amortization | 293K | 288K | 277K | 272K | 273K | 308K | 325K | 319K | 287K | 274K |